Unknown

Dataset Information

0

Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9.


ABSTRACT: The two published crystal structures of cytochrome P450 2C9, complexed with ( S)-warfarin or flurbiprofen, implicate a cluster of three active site phenylalanine residues (F100, F114, F476) in ligand binding. However, these three residues appear to interact differently with these two ligands based on the static crystal structures. To elucidate the importance of CYP2C9's active site phenylalanines on substrate binding, orientation, and catalytic turnover, a series of leucine and tryptophan mutants were constructed and their interactions with ( S)-warfarin and ( S)-flurbiprofen examined. The F100-->L mutation had minor effects on substrate binding and metabolism of each substrate. In contrast, the F114L and F476L mutants exhibited substantially reduced ( S)-warfarin metabolism and altered hydroxy metabolite profiles but only modestly decreased nonsteroidal antiinflammatory drug (NSAID) turnover while maintaining product regioselectivity. The F114-->W and F476-->W mutations also had opposing effects on ( S)-warfarin versus NSAID turnover. Notably, the F476W mutant increased the efficiency of ( S)-warfarin metabolism 5-fold, yet decreased the efficiency of ( S)-flurbiprofen turnover 20-fold. (1)H NMR T 1 relaxation studies suggested a slightly closer positioning of ( S)-warfarin to the heme in the F476W mutant relative to the wild-type enzyme, and stoichiometry studies indicated enhanced coupling of reducing equivalents to product formation for ( S)-warfarin, again in contrast to effects observed with ( S)-flurbiprofen. These data demonstrate that F114 and F476, but not F100, influence ( S)-warfarin's catalytic orientation. Differential interactions of F476 mutants with the two substrates suggest that their catalytically productive binding modes are not superimposable.

SUBMITTER: Mosher CM 

PROVIDER: S-EPMC2713172 | biostudies-literature | 2008 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Functional analysis of phenylalanine residues in the active site of cytochrome P450 2C9.

Mosher Carrie M CM   Hummel Matthew A MA   Tracy Timothy S TS   Rettie Allan E AE  

Biochemistry 20081016 45


The two published crystal structures of cytochrome P450 2C9, complexed with ( S)-warfarin or flurbiprofen, implicate a cluster of three active site phenylalanine residues (F100, F114, F476) in ligand binding. However, these three residues appear to interact differently with these two ligands based on the static crystal structures. To elucidate the importance of CYP2C9's active site phenylalanines on substrate binding, orientation, and catalytic turnover, a series of leucine and tryptophan mutant  ...[more]

Similar Datasets

| S-EPMC3201766 | biostudies-literature
| S-EPMC3531772 | biostudies-literature
| S-EPMC3257864 | biostudies-literature
| S-EPMC6824622 | biostudies-literature
| S-EPMC9923688 | biostudies-literature
| S-EPMC4723878 | biostudies-literature
| S-EPMC3154944 | biostudies-literature
| S-EPMC8820617 | biostudies-literature
| S-EPMC5761073 | biostudies-literature